{"id":"antiplatelet-or-anticoagulant-therapy","safety":{"commonSideEffects":[{"rate":"null","effect":"Gastrointestinal bleeding"},{"rate":"null","effect":"Thrombocytopenia"}]},"_chembl":{"chemblId":"CHEMBL2108251","moleculeType":"Oligosaccharide"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Antiplatelet agents work by inhibiting the activation and aggregation of platelets, which play a key role in the formation of blood clots.","oneSentence":"Inhibits platelet aggregation","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:34:44.020Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation"},{"name":"Acute coronary syndrome"}]},"trialDetails":[{"nctId":"NCT03568890","phase":"PHASE4","title":"Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2018-09-01","conditions":"Left Atrial Appendage Closure, Thrombosis, Stroke","enrollment":510},{"nctId":"NCT07496281","phase":"PHASE4","title":"OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2027-03-01","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent","enrollment":2},{"nctId":"NCT05387954","phase":"PHASE3","title":"PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-07-07","conditions":"Cryptogenic Ischemic Stroke, Patent Foramen Ovale","enrollment":792},{"nctId":"NCT07454707","phase":"PHASE3","title":"Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Stroke, Ischemic","enrollment":1204},{"nctId":"NCT06037889","phase":"PHASE3","title":"Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2023-11-09","conditions":"Branch Atheromatous Disease","enrollment":516},{"nctId":"NCT03950076","phase":"PHASE4","title":"EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-09-20","conditions":"Intracranial Hemorrhages, Atrial Fibrillation","enrollment":948},{"nctId":"NCT05832762","phase":"NA","title":"Evaluation of Acute Endovascular Treatment in Symptomatic Isolated Cervical Internal Carotid Artery Occlusion (ETICA)","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2024-08-19","conditions":"Acute Ischemic Stroke","enrollment":200},{"nctId":"NCT04045665","phase":"PHASE3","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-12-13","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":3200},{"nctId":"NCT07349875","phase":"PHASE4","title":"Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-01","conditions":"Coronary Artery Disease (CAD)","enrollment":3826},{"nctId":"NCT05845489","phase":"PHASE4","title":"Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2023-03-22","conditions":"Coronary Artery Disease","enrollment":11086},{"nctId":"NCT07269288","phase":"","title":"The Correlation and Mechanistic Study of GGCX Gene With Prognosis in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Peking University Aerospace Center Hospital","startDate":"2026-01-25","conditions":"Acute Ischemic Stroke","enrollment":1500},{"nctId":"NCT07013396","phase":"NA","title":"A Prospective Evaluation of Clinical Outcomes in Acute Ischemic Stroke After Endovascular Treatment w/Doppler","status":"NOT_YET_RECRUITING","sponsor":"Virginia Commonwealth University","startDate":"2027-02","conditions":"Anterior Cerebral Artery Syndrome, Anterior Cerebral Artery Stroke, Acute Ischemic Stroke","enrollment":100},{"nctId":"NCT07211854","phase":"","title":"Antithrombotic Strategies in Coronary Artery Dilatations and Aneurysms","status":"COMPLETED","sponsor":"Franck Assayag","startDate":"2024-09-06","conditions":"Coronary Artery Dilatations and Aneursyms","enrollment":51},{"nctId":"NCT07208695","phase":"","title":"Effect of Oral Antiplatelet or Anticoagulant Drugs on Postoperative Bleeding Risk and Venous Closure Rate in Patients With Lower Extremity Varicose Veins After Radiofrequency Ablation","status":"NOT_YET_RECRUITING","sponsor":"Chengdu University of Traditional Chinese Medicine","startDate":"2025-10-01","conditions":"Oral Antiplatele, Anticoagulant Drugs, Lower Extremity Varicose Veins","enrollment":40},{"nctId":"NCT03811769","phase":"NA","title":"Large Stroke Therapy Evaluation","status":"TERMINATED","sponsor":"University Hospital, Montpellier","startDate":"2019-04-07","conditions":"Stroke","enrollment":335},{"nctId":"NCT06665919","phase":"NA","title":"The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models","status":"COMPLETED","sponsor":"Vistamedi Ltd.","startDate":"2023-06-15","conditions":"Coronary Artery Disease, Clopidogrel Resistance, Coronary Thrombosis","enrollment":283},{"nctId":"NCT06702436","phase":"","title":"Invasive vs. Conservative Management in Cancer Patients With Non-ST Elevation MI (CAN-NSTEMI)\"","status":"COMPLETED","sponsor":"Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital","startDate":"2024-06-01","conditions":"Myocardial Infarction","enrollment":12500},{"nctId":"NCT06155032","phase":"NA","title":"Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion","status":"RECRUITING","sponsor":"First Affiliated Hospital of Wannan Medical College","startDate":"2024-01-04","conditions":"Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive","enrollment":272},{"nctId":"NCT07125417","phase":"PHASE4","title":"Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure","status":"RECRUITING","sponsor":"OCEAN-SHD Study Group","startDate":"2025-05-29","conditions":"Nonvalvular Atrial Fibrillation, Aspirin, Non-Antithrombotic Therapy","enrollment":500},{"nctId":"NCT07124728","phase":"NA","title":"Syntrillo Telehealth Stroke Risk Reduction Study","status":"NOT_YET_RECRUITING","sponsor":"Syntrillo, Inc","startDate":"2025-08","conditions":"Hypertension, Hypertension (HTN), Stroke Prevention","enrollment":68},{"nctId":"NCT04483583","phase":"PHASE4","title":"Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI","status":"COMPLETED","sponsor":"University of Florida","startDate":"2020-12-08","conditions":"Coronary Artery Disease","enrollment":81},{"nctId":"NCT07089030","phase":"NA","title":"Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy","status":"RECRUITING","sponsor":"Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec","startDate":"2023-06-06","conditions":"Obscure Gastrointestinal Bleeding, Iron-Deficiency Anemia, Antithrombotic Therapy","enrollment":20},{"nctId":"NCT05643651","phase":"PHASE4","title":"Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2025-06-01","conditions":"Kawasaki Disease, Coronary Artery Aneurysm","enrollment":100},{"nctId":"NCT05723926","phase":"NA","title":"Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation","status":"NOT_YET_RECRUITING","sponsor":"Javelin Medical","startDate":"2025-09-20","conditions":"Atrial Fibrillation, Oral Anticoagulation, Stroke","enrollment":2000},{"nctId":"NCT06564909","phase":"PHASE2","title":"Effect of L-Carnitine on Biomarkers of Myocardial Reperfusion Injury in Patients With STEMI","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-06-01","conditions":"Reperfusion Injury, Myocardial, Myocardial Infarction","enrollment":76},{"nctId":"NCT07016854","phase":"NA","title":"Early Endovascular Treatment in Isolated Internal Carotid Artery Occlusion","status":"RECRUITING","sponsor":"Sir Run Run Shaw Hospital","startDate":"2025-06","conditions":"Stroke, Acute Ischemic","enrollment":140},{"nctId":"NCT06983795","phase":"","title":"Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study","status":"NOT_YET_RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-07","conditions":"Ischemic Stroke, Patent Foramen Ovale","enrollment":1000},{"nctId":"NCT05641142","phase":"NA","title":"Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2023-04-07","conditions":"Hereditary Hemorrhagic Telangiectasia, Rendu Osler Disease","enrollment":100},{"nctId":"NCT06449469","phase":"NA","title":"The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2021-05-01","conditions":"Aortic Valve Stenosis, Cardiovascular Diseases, Heart Diseases","enrollment":352},{"nctId":"NCT05627375","phase":"PHASE3","title":"Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2023-08-16","conditions":"Venous Thromboembolic Disease","enrollment":1400},{"nctId":"NCT04347200","phase":"","title":"REGistry of Long-term AnTithrombotic TherApy-1","status":"RECRUITING","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2015-01-15","conditions":"Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Peripheral Artery Disease","enrollment":2000},{"nctId":"NCT03186729","phase":"PHASE4","title":"Study of Antithrombotic Treatment After IntraCerebral Haemorrhage","status":"TERMINATED","sponsor":"Oslo University Hospital","startDate":"2018-07-01","conditions":"Cerebral Hemorrhage, Intracranial Hemorrhages, Atrial Fibrillation","enrollment":134},{"nctId":"NCT03243175","phase":"PHASE3","title":"Avoiding Anticoagulation After IntraCerebral Haemorrhage","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2019-01-17","conditions":"Intracerebral Hemorrhage, Atrial Fibrillation, Microhaemorrhage","enrollment":300},{"nctId":"NCT02618577","phase":"PHASE3","title":"Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes","status":"TERMINATED","sponsor":"Atrial Fibrillation Network","startDate":"2016-02","conditions":"Atrial High Rate Episodes","enrollment":2608},{"nctId":"NCT05370105","phase":"","title":"Extracellular Vesicles as Stroke Biomarkers","status":"COMPLETED","sponsor":"Fondazione Don Carlo Gnocchi Onlus","startDate":"2018-06-25","conditions":"Stroke, Rehabilitation","enrollment":88},{"nctId":"NCT03996772","phase":"PHASE3","title":"PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2019-06-03","conditions":"Atrial Fibrillation, Intracerebral Hemorrhage","enrollment":319},{"nctId":"NCT06082063","phase":"PHASE3","title":"Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes","status":"RECRUITING","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2024-07-01","conditions":"Cardiovascular Diseases, Heart Failure, Type 1 Diabetes","enrollment":2000},{"nctId":"NCT03062319","phase":"PHASE4","title":"Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis","status":"TERMINATED","sponsor":"National Hospital Organization Osaka National Hospital","startDate":"2017-04-06","conditions":"Ischemic Stroke, Atrial Fibrillation, Atherothrombosis","enrollment":321},{"nctId":"NCT06680180","phase":"","title":"Fibrinolysis Resistance in Infection and Trauma","status":"RECRUITING","sponsor":"Anders Aneman","startDate":"2024-06-01","conditions":"Sepsis and Septic Shock, Trauma","enrollment":150},{"nctId":"NCT05360602","phase":"NA","title":"Alpha Lipoic Acid Effect on No-Reflow Phenomenon","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-01-01","conditions":"No-Reflow Phenomenon","enrollment":70},{"nctId":"NCT05028777","phase":"","title":"Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2021-01-01","conditions":"Thrombus of Left Ventricle","enrollment":550},{"nctId":"NCT06633809","phase":"","title":"Therapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion","status":"RECRUITING","sponsor":"Sir Run Run Shaw Hospital","startDate":"2021-11-22","conditions":"Stroke, Acute, Cerebrovascular Disorders, Brain Diseases","enrollment":200},{"nctId":"NCT05824923","phase":"PHASE3","title":"A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure","status":"RECRUITING","sponsor":"Pulnovo Medical (Wuxi) Co., Ltd.","startDate":"2023-08-14","conditions":"Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension","enrollment":264},{"nctId":"NCT05419583","phase":"NA","title":"Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2022-11-14","conditions":"Myocardial Infarction Type 2","enrollment":60},{"nctId":"NCT05507645","phase":"PHASE3","title":"ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2022-11-15","conditions":"Ischemic Stroke, Mild, Thrombosis","enrollment":1446},{"nctId":"NCT06558942","phase":"NA","title":"Incisional Negative Pressure Therapy to Prevent Animal Induced Wound Infection","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2024-08-20","conditions":"Injury Caused by Animal Bites, Wound Infection","enrollment":60},{"nctId":"NCT05151172","phase":"NA","title":"EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Michael D Hill","startDate":"2022-04-15","conditions":"Acute Ischemic Stroke","enrollment":530},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT04164693","phase":"NA","title":"Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula","status":"COMPLETED","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2019-01-01","conditions":"Thrombosis","enrollment":287},{"nctId":"NCT02830152","phase":"NA","title":"Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage","status":"ACTIVE_NOT_RECRUITING","sponsor":"Karolinska Institutet","startDate":"2017-05-03","conditions":"Atrial Fibrillation, Stroke, Intracerebral Hemorrhage","enrollment":750},{"nctId":"NCT03718559","phase":"PHASE4","title":"Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease","status":"COMPLETED","sponsor":"Gi-Byoung Nam","startDate":"2019-05-14","conditions":"Atrial Fibrillation, Coronary Artery Disease, Stable Angina","enrollment":1040},{"nctId":"NCT05204212","phase":"NA","title":"Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease","status":"RECRUITING","sponsor":"Prof. Dr. med. Ingo Eitel","startDate":"2022-03-28","conditions":"Non-valvular Atrial Fibrillation (NVAF): Paroxysmal, Persistent, Permanent","enrollment":430},{"nctId":"NCT06314022","phase":"NA","title":"A Mobile Application to Improve the Quality of Colonoscopy in Colorectal Cancer Screening Program (PrepColon APP)","status":"NOT_YET_RECRUITING","sponsor":"Hospital del Rio Hortega","startDate":"2024-05-02","conditions":"Colorectal Cancer, Premalignant Colon Lesions","enrollment":470},{"nctId":"NCT06058130","phase":"NA","title":"Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-09-29","conditions":"Acute Ischemic Stroke, Atrial Fibrillation, Stenosis, Carotid","enrollment":2171},{"nctId":"NCT05223335","phase":"PHASE4","title":"Clopidogrel Monotherapy in Patients With High Bleeding Risk","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-03-29","conditions":"Bleeding Complications","enrollment":98},{"nctId":"NCT06143488","phase":"NA","title":"Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Wannan Medical College","startDate":"2024-01-04","conditions":"Acute Ischemic Stroke, Mild Neurocognitive Disorder, Thrombectomy","enrollment":264},{"nctId":"NCT04436978","phase":"PHASE4","title":"What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?","status":"RECRUITING","sponsor":"St. Antonius Hospital","startDate":"2023-01-11","conditions":"Acute Coronary Syndrome, Myocardial Infarction, Atrial Fibrillation","enrollment":2000},{"nctId":"NCT03772366","phase":"","title":"Genital Haemorrhage in Woman of Childbearing Age Treated for Venous Thromboembolism Disease : Comparison According to Oral Anticoagulant and Impact on Quality of Life","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2019-06-01","conditions":"Genital Haemorrhage","enrollment":453},{"nctId":"NCT05761704","phase":"NA","title":"Exploratory Observation of Two Short-term Regimens After LAA Occlusion by LAMax LAAC® Device for Subjects With Non-valvular Atrial Fibrillation","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-11-16","conditions":"Non-valvular Atrial Fibrillation","enrollment":54},{"nctId":"NCT04551664","phase":"NA","title":"Study of Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients With a Large Infarct Core","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2020-10-02","conditions":"Acute Ischemic Stroke","enrollment":456},{"nctId":"NCT03796468","phase":"NA","title":"Minor Stroke Therapy Evaluation","status":"UNKNOWN","sponsor":"University Hospital, Montpellier","startDate":"2019-04-10","conditions":"Stroke","enrollment":824},{"nctId":"NCT04981041","phase":"PHASE4","title":"Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI","status":"UNKNOWN","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2021-12-16","conditions":"Acute Coronary Syndrome, Atrial Fibrillation","enrollment":2334},{"nctId":"NCT05852197","phase":"","title":"Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2023-01-01","conditions":"Anticoagulant Drugs, Antiplatelet Drug, Peripheral Arterial Disease","enrollment":6000},{"nctId":"NCT04006288","phase":"PHASE4","title":"Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease","status":"COMPLETED","sponsor":"University of Florida","startDate":"2019-09-06","conditions":"Coronary Artery Disease","enrollment":90},{"nctId":"NCT05552482","phase":"","title":"Identifying Risk Factors (RF) for Early Haemodialysis Arteriovenous Fistula Failure (eAVFF)","status":"COMPLETED","sponsor":"Centre Hospitalier Régional Metz-Thionville","startDate":"2021-01-05","conditions":"Arteriovenous Fistula, Hemodialysis, End Stage Chronic Renal Failure","enrollment":105},{"nctId":"NCT05690542","phase":"","title":"Nanoparticles in Blood: Understanding and Controlling Protein Corona for Optimized Nanomedicine","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2023-02","conditions":"Coagulation Tests","enrollment":60},{"nctId":"NCT03942913","phase":"","title":"Prospective Real-world Registry Describing Treatment Regimens","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2019-10-10","conditions":"Subject Under Anticoagulant","enrollment":573},{"nctId":"NCT05475080","phase":"","title":"Carotid Web and Stroke Registry.","status":"UNKNOWN","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2022-07-15","conditions":"Stroke, Carotid Web","enrollment":100},{"nctId":"NCT02835534","phase":"PHASE4","title":"The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI","status":"COMPLETED","sponsor":"CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.","startDate":"2016-05","conditions":"Acute ST Elevation Myocardial Infarction","enrollment":818},{"nctId":"NCT04741334","phase":"","title":"Mild Head Injury, Antiplatelets, and Anticoagulants","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2019-09-27","conditions":"Craniocerebral Trauma, Cerebral Hemorrhage","enrollment":2127},{"nctId":"NCT05098977","phase":"","title":"The Usefulness of Assessing Heart Rate Variability in Patients With Acute Myocardial Infarction","status":"UNKNOWN","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2021-11","conditions":"Myocardial Infarction, Autonomic Dysfunction","enrollment":200},{"nctId":"NCT01947959","phase":"","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-12-22","conditions":"Venous Thrombosis, Pulmonary Embolism, Atrial Fibrillation","enrollment":665533},{"nctId":"NCT02468102","phase":"","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-06-15","conditions":"Acute Coronary Syndrome, Venous Thrombosis, Pulmonary Embolism","enrollment":99999},{"nctId":"NCT01947985","phase":"","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)","status":"COMPLETED","sponsor":"Bayer","startDate":"2012-02-01","conditions":"Venous Thrombosis, Pulmonary Embolism, Atrial Fibrillation","enrollment":208958},{"nctId":"NCT01947998","phase":"","title":"Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-12-22","conditions":"Venous Thrombosis, Pulmonary Embolism, Atrial Fibrillation","enrollment":50299},{"nctId":"NCT03023020","phase":"NA","title":"Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen","status":"COMPLETED","sponsor":"ECRI bv","startDate":"2017-04-04","conditions":"High Bleeding Risk, Coronary Artery Disease, PCI","enrollment":4579},{"nctId":"NCT03362788","phase":"","title":"The Greek AntiPlatElet Atrial Fibrillation Registry.","status":"COMPLETED","sponsor":"Attikon Hospital","startDate":"2017-12-01","conditions":"Atrial Fibrillation, Coronary Artery Disease","enrollment":654},{"nctId":"NCT02565693","phase":"PHASE2","title":"Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2014-09","conditions":"Cerebral Hemorrhage, Atrial Fibrillation","enrollment":101},{"nctId":"NCT02664649","phase":"PHASE3","title":"Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-08-26","conditions":"Symptomatic Aortic Stenosis, Eligible for Transcatheter Aortic Valve Replacement","enrollment":1510},{"nctId":"NCT03288441","phase":"","title":"Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia","status":"UNKNOWN","sponsor":"Maastricht University Medical Center","startDate":"2018-03-20","conditions":"Hematologic Neoplasms, Thrombocytopenia, Anticoagulants","enrollment":300},{"nctId":"NCT03073850","phase":"PHASE4","title":"Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation","status":"TERMINATED","sponsor":"Korea University Guro Hospital","startDate":"2017-02-23","conditions":"Atrial Fibrillation","enrollment":48},{"nctId":"NCT04518735","phase":"","title":"Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2020-04-01","conditions":"Covid19","enrollment":1707},{"nctId":"NCT02789917","phase":"PHASE4","title":"APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF","status":"COMPLETED","sponsor":"LMU Klinikum","startDate":"2016-06","conditions":"Acute Coronary Syndrome, Atrial Fibrillation, Coronary Artery Disease","enrollment":403},{"nctId":"NCT04291287","phase":"","title":"Triple or Dual Antithrombotic Therapy After PCI (TRIDUAL-PCI) Coronary Intervention in Patients With Non-valvular Atrial Fibrillation. Real-world Italian Multicenter Registry (TRIDUAL-PCI)","status":"UNKNOWN","sponsor":"Scientific Institute San Raffaele","startDate":"2020-01-25","conditions":"Atrial Fibrillation, Myocardial Infarction, Anticoagulant-induced Bleeding","enrollment":1500},{"nctId":"NCT02635230","phase":"","title":"What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.","status":"UNKNOWN","sponsor":"R&D Cardiologie","startDate":"2014-06","conditions":"Atrial Fibrillations, Heart Valve Prostheses, Acute Coronary Syndromes","enrollment":2200},{"nctId":"NCT03415386","phase":"PHASE4","title":"Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2020-06","conditions":"Acute Myocardial Infarction, Left Ventricular Thrombus","enrollment":120},{"nctId":"NCT03157154","phase":"","title":"Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2017-06-27","conditions":"Hemophilia","enrollment":259},{"nctId":"NCT04153201","phase":"NA","title":"Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2013-01-15","conditions":"Antiphospholipid Syndrome","enrollment":50},{"nctId":"NCT01727427","phase":"","title":"Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients","status":"COMPLETED","sponsor":"G. d'Annunzio University","startDate":"2012-11","conditions":"Unsuspected Pulmonary Embolism","enrollment":695},{"nctId":"NCT04047667","phase":"","title":"Cone Beam CT Guided Transbronchial Cryobiopsy","status":"UNKNOWN","sponsor":"China-Japan Friendship Hospital","startDate":"2018-09-01","conditions":"ILD","enrollment":160},{"nctId":"NCT03970421","phase":"","title":"Severity Factors and Needed Observation Time at ED of Patients Wih Head Injury","status":"UNKNOWN","sponsor":"Hospital El Escorial","startDate":"2019-06","conditions":"Head Injury Other, Length of Stay, Delayed Complications","enrollment":300},{"nctId":"NCT03067909","phase":"","title":"Antithrombotic Therapy in Patients Undergoing CIED Surgery - HEMATOMA NO MORE Registry","status":"COMPLETED","sponsor":"Azienda Ospedaliera Universitaria Senese","startDate":"2016-05","conditions":"Device Related Infection, Antithrombotic Drugs, Cardiac Arrhythmia","enrollment":1450},{"nctId":"NCT03818451","phase":"NA","title":"Co-ultra PEALut Enhances Neuronal Recovery Following Moderate Traumatic Brain Injury","status":"UNKNOWN","sponsor":"University of Messina","startDate":"2016-05-01","conditions":"Traumatic Brain Injury","enrollment":60},{"nctId":"NCT03275077","phase":"","title":"To Compare TEG (Thrombelastography) and Conventional Tests in CKD Patients","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2016-03-12","conditions":"End Stage Renal Disease, Coagulopathy","enrollment":100},{"nctId":"NCT01962545","phase":"PHASE4","title":"Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study","status":"COMPLETED","sponsor":"Satoshi Shizuta","startDate":"2013-11-05","conditions":"Atrial Fibrillation, Coronary Artery Disease","enrollment":690},{"nctId":"NCT02750579","phase":"NA","title":"Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes?","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2016-09-05","conditions":"Acute Coronary Syndrome","enrollment":740},{"nctId":"NCT00562289","phase":"PHASE3","title":"Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2007-12","conditions":"Ischemic Stroke, Patent Foramen Ovale, Atrial Septal Aneurysm","enrollment":664},{"nctId":"NCT02723981","phase":"PHASE4","title":"COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials","status":"WITHDRAWN","sponsor":"IHF GmbH - Institut für Herzinfarktforschung","startDate":"2016-04","conditions":"Stable Angina, Unstable Angina, STEMI","enrollment":""},{"nctId":"NCT02826200","phase":"PHASE4","title":"Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography (RETORIC)","status":"UNKNOWN","sponsor":"Semmelweis University Heart and Vascular Center","startDate":"2016-07","conditions":"Prosthetic Cardiac Valve Thrombosis, Cerebrovascular Accident, Prosthetic Valve Malfunction","enrollment":200},{"nctId":"NCT00238667","phase":"PHASE3","title":"To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection","status":"COMPLETED","sponsor":"St George's, University of London","startDate":"2005-11","conditions":"Cervical Artery Dissection, Carotid Artery Dissection, Vertebral Artery Dissection","enrollment":250}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":58681,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"Antiplatelet or Anticoagulant Therapy","genericName":"Antiplatelet or Anticoagulant Therapy","companyName":"Syntrillo, Inc","companyId":"syntrillo-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Inhibits platelet aggregation Used for Atrial fibrillation, Acute coronary syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}